Ten-Year Follow-Up of the First Megatrial Testing Thrombolytic Therapy in Patients With Acute Myocardial Infarction

Maria Grazia Franzosi; Eugenio Santoro; Claudio De Vita; Enrico Geraci; Antonio Lotto; Aldo Maggioni; Francesco Mauri; F Rovelli; Luigi Santoro; Luigi Tavazzi; Gianni Tognoni

doi:10.1161/01.cir.98.24.2659

Abstract

1 min read

The benefits of a single intravenous infusion of 1.5 million units of streptokinase in prolonging survival of patients with acute myocardial infarction is sustained up to 10 years, with a still-evident trend in favor of the patients admitted earlier.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1987

In-Hospital Prognosis of Patients with Acute Myocardial Infarction Complicated by Primary Ventricular Fibrillation

Alberto Volpi, Aldo Maggioni, Maria Grazia Franzosi, S. Pampallona, Francesco Mauri, Gianni Tognoni

Article1992

The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment

Aldo Maggioni, M. G. Franzosi, Eugenio Santoro, Harvey D. White, Frans Van de Werf, Gianni Tognoni

Article1986

Thrombolytic Therapy for Acute Coronary Obstruction: Status in 1986

Philip Hugenholtz, Patrick W. Serruys

Article1985

Bleeding complications of intracoronary fibrinolytic therapy in acute myocardial infarction. Assessment of risk in a randomised trial.

Freek W.A. Verheugt, Machiel J. van Eenige, J C, Maarten L. Simoons, Patrick W. Serruys, Frank Vermeer, D C van Hoogenhuyze, Pim Remme, C. de Zwaan, F. M. Baer

Heart

Article1986

Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?

Frank Vermeer, Maarten L. Simoons, Frits W. Bär, Jan G.P. Tijssen, Ron T. van Domburg, Patrick W. Serruys, Freek W.A. Verheugt, J C, C. de Zwaan, Arnoud van der Laarse

Circulation